Sahil
Analyst
RBC
Equibles does not estimate personal net worth.
About Sahil
Sahil is recorded as Analyst at RBC. Sahil has spoken on 1 earnings call across 1 company, most recently for Aurinia Pharmaceuticals Inc. on February 26, 2026. The companies whose calls Sahil spoke on are classified in the Healthcare sector.
Sahil on recent calls
“My question is related to the competitive landscape. So we have seen that GAZAIWA was recently approved in the LN indication. So first question is, have you seen any impact of the positioning of leukinase in the treatment landscape following that launch?”
Affiliation history
-
RBC
Analyst
Transcript header (unverified)
Current